Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Treatment
  6. Prasugrel (Effient)

Prasugrel (Effient)

  • Angina (18)
  • Antithrombotics (394)
  • Arrhythmias (187)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (105)
  • Dyslipidemia (283)
  • Endocarditis (21)
  • Heart Disease (88)
  • Heart Failure (205)
  • Hypertension (330)
  • Hypotension (22)
  • Ischemic Heart Disease/Acute Coronary Syndromes (369)
    • Cardiovascular Markers (29)
    • Drug-Induced Ischemic Heart Disease (40)
    • Guidelines (4)
    • Prevention (69)
    • Treatment (287)
      • ACEIs (68)
      • Anticoagulants (36)
      • ARBs (63)
      • ARNIs (8)
      • Aspirin (86)
      • Beta-Blockers (79)
      • Calcium Channel Blockers (27)
      • Clopidogrel (Plavix) (53)
      • Natural Medicines/Supplements (8)
      • Nitrates (14)
      • Prasugrel (Effient) (29)
      • Statins (47)
  • Myocardial Infarction (45)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (3)
  • Resources (964)
  • Stroke (181)
16 - 29 of 29 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Discontinuing Antiplatelet Agents September 2011
Commentary: Discontinuing Antiplatelet Agents September 2011
Article: Brilinta (ticagrelor) will compete with Plavix and Effient July 2011
Commentary: New Drug: Brilinta (Ticagrelor) July 2011
Article: whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients February 2011
Article: how to use PPIs in patients taking clopidogrel (Plavix) January 2011
Article: Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty June 2010
Article: whether patients should get genetic tests to help determine dosing for warfarin or clopidogrel (Plavix) May 2010
Article: a specific list of drugs to avoid with Plavix January 2010
Article: whether proton pump inhibitors decrease the efficacy of clopidogrel (Plavix) November 2009
Article: warfarin used in combo with aspirin AND clopidogrel (Plavix) in more cardiac patients September 2009
Guideline: Primary and Secondary Prevention of Coronary Artery Disease (ACCP, 8th edition) September 2009
Guideline: Percutaneous Coronary Intervention (ACC/AHA/SCAI, 2007 Update) September 2009
Article: proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix) April 2009
  • « Prev
  • 1
  • 2
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved